Nanoform Valuation Multiples

Nanoform Overview

About Nanoform

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceuticals pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.

Founded

2015

HQ

Employees

181

Website

nanoform.com

Sectors

Contract Research & ManufacturingBioTech

Financials (LTM)

Revenue: $5M

EBITDA: ($17M)

EV

$37M

Valuation Multiples

Multiples.vc

Start free trial

Nanoform Financials

Nanoform reported last 12-month revenue of $5M and negative EBITDA of ($17M).

In the same LTM period, Nanoform generated $4M in gross profit, ($17M) in EBITDA losses, and had net loss of ($19M).

Nanoform P&L

In the most recent fiscal year, Nanoform reported revenue of $4M and EBITDA of ($17M).

Nanoform expects next 12-month revenue of XXX and NTM EBITDA of XXX

Nanoform Stock Performance

Nanoform has current market cap of $58M, and enterprise value of $37M.

Nanoform's stock price is $0.67.

Nanoform Valuation Multiples

Nanoform trades at 8.0x EV/Revenue multiple, and (2.2x) EV/EBITDA.

Nanoform Financial Valuation Multiples

As of April 19, 2026, Nanoform has market cap of $58M and EV of $37M.

Equity research analysts estimate Nanoform's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Nanoform has a P/E ratio of (3.0x).

Nanoform Margins & Growth Rates

Nanoform's revenue in the last 12 month grew by 46%.

Nanoform's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.

Nanoform's rule of 40 is (173%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nanoform's rule of X is (121%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Nanoform Public Comps

See public comps and valuation multiples for other Contract Research & Manufacturing comps.

Nanoform M&A Activity

Nanoform acquired XXX companies to date.

Last acquisition by Nanoform was on XXXXXXXX, XXXXX. Nanoform acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Nanoform Investment Activity

Nanoform invested in XXX companies to date.

Nanoform made its latest investment on XXXXXXXX, XXXXX. Nanoform invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).